Showing results (471-480 of 504) with videos related to

Sort By:
Pageof 51
The Lancet. Haematology|January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling studyJavier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Frontiers in Immunology|October 3, 2022
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human bloodKyra van der Pan, Sandra de Bruin-Versteeg, Daniela Damasceno, et al.
Hemasphere|May 27, 2025
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trialsCelia González-Gil, Thaysa Lopes, Mireia Morgades, et al.
Science Translational Medicine|February 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivoLaura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, et al.
The Lancet. Oncology|August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaShaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Blood|April 17, 2020
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myelomaCatarina Maia, Noemi Puig, Maria-Teresa Cedena, et al.
Leukemia Research|June 17, 2021
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)Eulàlia Genescà, Mireia Morgades, Celia González-Gil, et al.
Blood|March 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemiaAïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti, et al.
Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.
Pageof 51